Le Lézard
Classified in: Health
Subjects: MAV, POL, NTA, FVT, CFG

UPDATE - Media Advisory - Minister Philpott to visit Winnipeg and make announcements regarding First Nations education and health transformation

The location has been updated

WINNIPEG, Sept. 5, 2018 /CNW/ - Please be advised that the Honourable Jane Philpott, Minister of Indigenous Services will be in Winnipeg on Thursday, September 6, 2018, and will participate in two announcements.

In the morning, Minister Philpott will attend the grand opening of the expanded campus of Southeast Collegiate in Winnipeg, a secondary school that welcomes First Nations students from communities across Manitoba.

Following this event, Minister Philpott will make an important funding announcement for regional First Nations-led health transformation alongside Manitoba Keewatinowi Okimakanak (MKO).

The Minister will be available after each event to respond to questions from the media.

Southeast Collegiate Grand Opening
September 6, 2018
Time: 10:30 a.m. (CDT)
Where: Southeast Collegiate
1269 Lee Blvd., Winnipeg, MB
R3T 5W8

Health Transformation Funding Announcement
Date: September 6, 2018                          
Time: 2:00 p.m. (CDT)
Where: 275 Portage Ave, 16th floor
Winnipeg, Manitoba
R3B 2B3

Follow us on Twitter:
Minister Jane Philpott

GovCan ? Indigenous


SOURCE Indigenous Services Canada

These press releases may also interest you

at 18:00
ATLANTA, Oct. 19, 2018 /PRNewswire-PRWeb/ -- The founder of SCF (Shaolin Chan Foundation & GZC (Global Zen Consciousness Conference), DeRu (Shawn X. Liu) will speak on Zen consciousness in relation to global issues and solutions at Harvard University...

at 17:55
Sanofi (EURONEXT: SAN) The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral...

at 17:55
Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, regardless of phenotype Only asthma biologic that offers patient self-administration at...

at 17:49
SI-BONE, Inc. ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the closing of its initial public offering of 8,280,000 shares of...

at 17:00
The "Neurostimulation Devices Market (2nd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The Neurostimulation Devices Market (2nd Edition), 2018-2030' report features an extensive study of the current landscape and...

at 16:39
In the cannabis industry safety and quality should be the highest priority of any producer and Evergreen Organix takes this responsibility to heart. All their signature products use only the finest ingredients and premium cannabis that is grown in a...

News published on 6 september 2018 at 09:11 and distributed by: